Guangzhou Baiyunshan Pharmaceutical Holdings
600332.SSGuangzhou Baiyunshan Pharmaceutical Holdings is a leading Chinese pharmaceutical company listed on the Shanghai Stock Exchange with a market capitalization of approximately $5.9 billion. The company operates through multiple subsidiaries covering traditional Chinese medicine, modern pharmaceuticals, and consumer healthcare products. With a strong presence in the domestic Chinese market, Baiyunshan has established itself as a major player in China's pharmaceutical industry through both organic growth and strategic acquisitions.
600332.SS · Stock Price
Historical price data
AI Company Overview
Guangzhou Baiyunshan Pharmaceutical Holdings is a leading Chinese pharmaceutical company listed on the Shanghai Stock Exchange with a market capitalization of approximately $5.9 billion. The company operates through multiple subsidiaries covering traditional Chinese medicine, modern pharmaceuticals, and consumer healthcare products. With a strong presence in the domestic Chinese market, Baiyunshan has established itself as a major player in China's pharmaceutical industry through both organic growth and strategic acquisitions.
Technology Platform
Diversified pharmaceutical platform combining traditional Chinese medicine formulations with modern chemical pharmaceutical manufacturing and consumer healthcare products.
Pipeline
3| Drug | Indication | Stage | Watch |
|---|---|---|---|
| placebo of oseltamivir phosphate + oseltamivir phosphate + B... | Influenza | Approved | |
| Huatuo Zaizao Pills | Ischemic Stroke | Approved | |
| Fufangdanshen Tablets + Placebo | Vascular Dementia | Phase 2 |
Opportunities
Risk Factors
Competitive Landscape
Competes with major Chinese pharmaceutical companies like China Resources Pharmaceutical and Sinopharm, differentiated by its combination of traditional Chinese medicine expertise and modern pharmaceutical capabilities.